Annis Gardner Whiting Capital Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-90
Closed -$11.2K – 1387
2025
Q2
$11.2K Buy
+90
New +$11.5K ﹤0.01% 691
2025
Q1
– Sell
-1,240
Closed -$178K – 806
2024
Q4
$178K Hold
1,240
– – 0.05% 215
2024
Q3
$185K Sell
1,240
-58
-4% -$8.32K 0.05% 215
2024
Q2
$164K Buy
1,298
+435
+50% +$68.2K 0.05% 231
2024
Q1
$159K Buy
863
+58
+7% +$11K 0.06% 218
2023
Q4
$145K Buy
805
+205
+34% +$31.9K 0.06% 184
2023
Q3
$95.4K Buy
+600
New +$98.1K 0.05% 217

Other funds holding RGEN

Annis Gardner Whiting Capital Advisors's RGEN Position: Q3 2025 in Review

Annis Gardner Whiting Capital Advisors sold out of Repligen (RGEN) in Q3 2025, closing a stake of 90 shares — an estimated $11.2K sold.

Annis Gardner Whiting Capital Advisors first reported a position in RGEN in Q3 2023 and held it in 7 quarters. The position peaked at $185K in Q3 2024. 453 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

  • Annis Gardner Whiting Capital Advisors reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 90 Repligen shares in Q3 2025, an estimated $11.2K.
  • Annis Gardner Whiting Capital Advisors first reported a position in Repligen in Q3 2023 and held it in 7 quarters.
  • Annis Gardner Whiting Capital Advisors's Repligen position peaked at $185K in Q3 2024.
  • 453 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q3 2025, filed 3 Nov 2025.